Synopsys heads into the back half of 2026 with a quiet but persistent buildup in short positions, even as the Street remains broadly constructive and the borrow market shows no sign of stress.
The most striking feature in the data this week is how much short interest has grown without any corresponding tightening in the lending market. Short interest has climbed 32% over the past month to reach 3.2% of the free float — a meaningful acceleration from the ~2.8% level noted in mid-June. Yet the borrow pool remains extraordinarily deep, with availability running at effectively uncapped levels and a cost to borrow of just 0.44%. That combination — rising shorts, plentiful supply — means new bears are walking in cheaply and easily. Days to cover from FINRA's fortnightly count holds at just over three days, so the short book isn't positioned for a prolonged squeeze campaign. Options traders are leaning modestly defensive too: the put/call ratio is running at 1.17, above its 20-day average of 1.13, though the z-score of 0.37 puts it well short of an alarm signal. The 52-week high on the PCR was 1.35, hit on June 22 — the current read represents a mild easing from that peak but remains elevated relative to May, when the ratio spent several sessions below 1.0.
The Street's direction is clearer than the positioning. Piper Sandler upgraded to Overweight on June 23, lifting its target from $450 to $550 — the most recent analyst action and a meaningful shift given the firm had been neutral. The broader analyst pack moved targets sharply higher in late May following the FY26 guidance raise: BofA lifted its target to $600 from $515, Citigroup to $610, and Stifel to $600, all maintaining Buy ratings. The consensus mean target of ~$564 implies roughly 24% upside from the current price of $454. The holdout on the other side is BNP Paribas, which maintains an Underperform at a $450 target — effectively flagging the stock as fully valued at current levels. On multiples, the trailing PE has compressed about five points over 30 days to just over 29x, while EV/EBITDA has drifted up to 23.8x. Factor scores are mixed: forward EPS momentum ranks in the 70th percentile, but the EPS surprise score is low at 19, and analyst recommendation differential sits at just the 6th percentile — reflecting the thinness of the upgrade cycle.
The earnings backdrop adds context to the caution. SNPS fell 10.1% the day after its May 27 print, and was still down 6.8% five days later. That kind of post-earnings drawdown tends to invite incremental hedging ahead of the next release. The next earnings event is scheduled for August 26 — still eight weeks out, but close enough to explain some of the put activity building in the options market. The bull case rests on EDA market leadership, AI-driven demand for design tools, and continued Elliott Management engagement following Jesse Cohn's board appointment. Bears point to rich multiples, the sale of the Processor IP business weighing on near-term revenues, and the May print's negative market reaction even against a guidance raise.
Closest peer CDNS gained 1.4% on the week, while SNPS fell 2.0% — a modest but notable divergence between the two EDA duopolists. MSFT and OTEX both posted stronger weekly gains of 5.1% and 7.8% respectively, underlining that the software sector broadly is performing better than the EDA names right now.
Overall, positioning looks cautious rather than crowded: a rising short book paired with cheap, abundant borrow and a mildly elevated put/call ratio suggests the market is hedging around the August print rather than making a high-conviction directional bet — and the August 26 report will therefore be as much a referendum on whether the May selloff was an overreaction as it is on the underlying business.
See the live data behind this article on ORTEX.
Open SNPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
